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Abstract
In response to the high co-occurrence of anxiety symptoms in youth with autism spectrum 
disorder (ASD), several interventions have been developed for this population. In spite of 
promising findings, some youth with ASD respond only minimally to anxiety interventions. The 
current study explores the role of parental anxiety in youth treatment outcome. Thirty-one youth 
with ASD, ages 7–18, and their parents participated in the study. Parents completed the State-Trait 
Anxiety Inventory pre- and post-treatment. Contrary to previous research, there was no correlation 
between parental anxiety and youth anxiety at baseline or post-treatment. However, parental trait 
anxiety significantly decreased from pre- to post-treatment for parents of treatment responders. 
The findings are consistent with previous research and suggest youth-to-parent influence.
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Anxiety disorders are among the most common psychiatric conditions in children and 
adolescents (Walkup et al., 2008). Not only are clinical anxiety symptoms prevalent in the 
general pediatric population, but recent research indicates that anxiety symptoms occur at 
higher rates in youth with autism spectrum disorder (ASD) (de Bruin, Ferdinand, Meester, 
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de Nijs, & Verheij, 2007; Leyfer et al., 2006; van Steensel, Bogels, & Perrin, 2012>). Over 
the past five years, a number of randomized controlled trials examining the efficacy of 
modified cognitive behavior therapy (CBT) interventions for youth with ASD and anxiety 
have demonstrated significant reductions in anxiety symptoms following participation (e.g., 
Reaven, Blakeley-Smith, Culhane-Shelburne, & Hepburn, 2012a; Storch et al., 2013; White 
et al., 2013; Wood et al., 2009). Although these programs have demonstrated success in 
reducing anxiety symptoms, arguably, none of these interventions can claim complete 
success, since a portion of children demonstrate only modest improvements in anxiety 
symptoms or do not respond to treatment at all (Reaven et al., 2012a). Indeed, studies 
generally report that between 20% and 50% of participants display modest to little positive 
response to anxiety interventions (White et al., 2013; Wood et al., 2009).
Given that there continues to be a subset of youth with ASD who do not demonstrate 
clinically meaningful reductions in anxiety symptoms following participation in modified 
CBT interventions, it is important to understand the factors that may influence treatment 
response. Parent variables, particularly parental anxiety, may be important to explore, given 
the extent to which parenting behaviors appear to play a role in the development and 
maintenance of anxiety symptoms in typically developing children (Creswell, Schniering, & 
Rapee, 2005; Ginsburg & Schlossberg, 2002; McClure, Brennan, Hammen, & Le Brocque, 
2001; Rapee, Schniering, & Hudson, 2009). Further, it has long been reported that anxious 
children are more likely to have anxious parents relative to their non-anxious peers; in fact, 
maternal lifetime history of anxiety may double the risk for anxiety in children (McClure et 
al., 2001).
Although the mode of anxiety transmission from one generation to another is unclear and 
complicated by shared genetic influence (Rapee et al., 2009), some researchers hypothesize 
that “interpretation bias” (the cognitive interpretation of ambiguous situations as 
threatening) may contribute to the development of anxiety in children, since children 
observe their parent’s behavior and through modeling, may internalize their parent’s 
“maladaptive” cognitions (Creswell et al., 2005). In fact, clinically anxious children interpret 
ambiguous situations as significantly more threatening than non-anxious children, and 
maternal and child threat interpretations are significantly correlated (Creswell et al., 2005). 
When stimuli are perceived as threatening, avoidant behavior may develop. Avoidance may 
lead to decreased opportunity to manage fearful situations, which in turn results in fewer 
chances to develop alternative coping behaviors (Reaven & Hepburn, 2006). Avoidant 
coping may also lead to a decreased sense of competence and further avoidance of feared 
stimuli, contributing to the maintenance of anxiety over time (Dadds & Barrett, 2001; 
Manassis & Bradley, 1994).
In an effort to enhance treatment effects for child participants in the general (typically 
developing) literature, recent research has targeted parent variables as part of youth anxiety 
treatment programs; however, these studies have yielded mixed results (Cobham, Dadds, & 
Spence, 1998; Creswell, Willetts, Murray, Singhal & Cooper, 2008). On the one hand, when 
parental anxiety was targeted as part of a child anxiety treatment program, the efficacy of 
the CBT treatment increased for children of anxious parents, while treatment efficacy did 
not increase for children of non-anxious parents (Cobham et al., 1998). Other treatment 
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studies have found that although children with anxious parents did less well compared to 
their counterparts with non-anxious parents, treating maternal anxiety did not improve child 
treatment outcome, suggesting that other parenting factors such as over-involvement may be 
a better target for intervention (Creswell et al., 2008).
Additional research has explored the reciprocal influence and bidirectional nature of the 
parent-child relationship in the treatment of childhood anxiety in the typically developing 
population (Silverman, Kurtines, Jaccard, & Pina, 2009). Rather than targeting parent 
factors (e.g., parental anxiety) as a way to improve childhood anxiety, some studies suggest 
that targeting youth anxiety is the key to creating corresponding improvements in parent 
variables. In a treatment study with children ages 7–16, Silverman and colleagues (2009) 
found that when children’s symptoms improved, corresponding improvements were also 
noted in parental anxiety, providing preliminary support for youth-to-parent treatment 
influence.
Very few studies have explored the relationship between parental anxiety and anxiety in 
youth with ASD. However, it is known that parents of children with ASD experience more 
psychiatric symptoms than do parents of typically developing children or children with other 
developmental disabilities (Murphy et al., 2000; Rao & Beidel, 2009). In addition, parents 
face greater burdens caring for children with ASD compared with parents of typically 
developing children, which may lead to high rates of caregiver stress (Estes et al., 2009; 
Lecavalier, Leone & Wiltz, 2006; Orsmond, Seltzer, Greenberg & Krauss, 2006). Constant 
caregiving, with little relief even as children move through adolescence and into young 
adulthood, tends to be the norm rather than the exception for families of children with ASD 
(Reaven, 2011). Several studies have implicated the presence of maladaptive behavior as 
greatly contributing to caregiver stress (Estes et al., 2009; Lecavalier, et al., 2006). In efforts 
to manage these behaviors, parents of youth with ASD may adopt a protective parenting 
style towards their children, who by definition present with marked challenges in social 
functioning, communication, and behavior (Reaven & Hepburn, 2006). Thus, for families of 
youth with ASD, parental anxiety and stress may be inextricably woven into parenting 
behaviors, and distinguishing between when to protect youth and when to encourage youth 
to face fears can be challenging (Reaven & Hepburn, 2006).
Conner, Maddox, & White (2013) examined the relationship between parental state and trait 
anxiety and treatment response in adolescents with ASD in one of the first studies to 
empirically investigate the potential association. Multimodal Anxiety and Social Skills 
Intervention (MASSI; White et al., 2013) was the treatment implemented in this study. 
MASSI consists of three main treatment components: parent involvement, individual 
therapy, and group therapy. Core elements of the program included psychoeducation about 
ASD and anxiety, social skill development, and exposure practice. The researchers 
examined whether parental state (anxiety at the moment) or trait anxiety (chronic anxiety 
symptoms) influenced parent report of adolescent anxiety symptoms. Thirty adolescents, 
ages 12–17, participated in the study, along with both their mothers (n = 29) and their 
fathers (n = 29). Results indicated that parental state anxiety was significantly correlated 
with parent report of anxiety in teens. Further, significant decreases in parental trait anxiety 
were apparent post-treatment for parents of treatment responders, but not for parents of 
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treatment non-responders, providing preliminary evidence of youth-to-parent influence in 
ASD families.
The purpose of the present study was to examine the relationship between parental anxiety 
and response to treatment in youth with ASD, and to determine whether the findings 
reported by Conner et al. (2013) would replicate with a sample of participants with a greater 
age range (7–18 years), with a mix of fathers and mothers as parent participants, and with a 
similar but non-identical intervention. Specifically, the objectives of the present study were 
to: 1) explore the relationship between parental anxiety and parent report of anxiety in youth 
with ASD; and 2) examine the relationship between parental anxiety and youth treatment 
outcome, especially for parents of treatment responders vs. non-responders. Similar to 
previous research, it was hypothesized that parental anxiety would be positively correlated 
with parent report of youth anxiety. It was also hypothesized that parents of treatment 




Families were recruited through Colorado Multiple Institution Review Board (COMIRB)-
approved study announcements, which were mailed to local schools, clinics, and parent 
groups. Informed consent and assent were obtained from all study participants prior to data 
collection and treatment.
The study drew upon two participant cohorts that were part of larger ongoing research 
projects examining the nature and treatment of anxiety in children with ASD. The school-
aged cohort included 10 families of children between the ages of 7 and 14 years (M = 10.4 
years, SD = 2.2) who participated in a randomized controlled trial of Facing Your Fears: 
Group Therapy for Managing Anxiety in Children with High-Functioning Autism Spectrum 
Disorders (FYF) (see Reaven, Blakeley-Smith, Nichols & Hepburn, 2011). The adolescent 
cohort included 21 families of teens between the ages of 13 and 18 (M = 15.5 years, SD = 
1.3) who were involved in the adolescent adaptation of the intervention (see Reaven, 
Blakeley-Smith, Leuthe, Moody & Hepburn, 2012b). The total sample comprised 31 youth 
(Mage = 13.8 years, SD = 3.0) with ASD and anxiety and their parents (Mage = 44.4 years, 
SD = 9.1). Participant characteristics are summarized in Table 1. In the majority of cases 
(84%), mothers were the respondents on study measures.
Inclusion criteria for youth participants were: (a) chronological age of 7–14 years for the 
school-aged cohort and 13–18 years for the adolescent cohort; (b) confirmed diagnosis of 
ASD, as determined by expert clinical review of an Autism Diagnostic Observation Schedule 
(ADOS; Lord, Rutter, DiLavore, & Risi, 2002) administered within a year prior to 
treatment, the Social Communication Questionnaire (SCQ; Berument, Rutter, Lord, Pickles, 
& Bailey, 1999), and a background questionnaire including questions regarding early 
language milestones; (c) ability to speak in full, complex sentences, reflected in the ability to 
complete Module 3 or 4 of the ADOS; (d) estimated verbal IQ of 70 or higher on a 
standardized cognitive evaluation administered within two years prior to recruitment; and (e) 
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clinically significant anxiety symptoms, defined by a score above the clinical cutoff for 
social (SOC), separation (SEP), and/or generalized anxiety (GAD) on the Screen for Child 
Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999)—Parent version.
Participants were excluded if: (a) the child’s primary psychiatric symptoms reflected another 
condition such as depression or psychosis; (b) the child displayed significant problem 
behaviors or psychiatric illness that prevented them and others from accessing the FYF 
curriculum; or (c) one parent could not commit to attending at least 80% of treatment 
sessions. (For further participant details, see Reaven et al., 2012a, 2012b.)
Procedure
Study procedures were completed in compliance with COMIRB for both the school-aged 
and adolescent cohorts. Families contacted the research clinic and received information 
regarding study goals and procedures. If the study was of interest to the parent, a research 
assistant conducted a brief telephone screen for eligibility. If the child was a potentially 
eligible participant, the family was invited to the research clinic to complete a battery of 
measures including ASD assessment, cognitive testing (if necessary), anxiety measures, and 
additional assessments not reported in this study. Families were compensated for their 
participation in the assessment, both pre- and post-intervention.
FYF intervention—The FYF intervention is a 14-week, group cognitive behavior therapy 
(CBT) program designed to reduce anxiety symptoms in youth with high-functioning ASD. 
Two separate intervention manuals were created for the school-aged and adolescent age 
groups (Reaven et al., 2011; Reaven et al., unpublished manual). Although the sequence and 
delivery format of intervention strategies differed slightly for school-aged and adolescent 
groups given their different developmental needs, both intervention groups received the 
critical components of CBT (i.e., graded exposure, somatic management, cognitive self-
control, and a focus on improving emotion regulation). Modifications to traditional CBT 
activities were made in order to meet the cognitive, linguistic, and social needs of youth with 
ASD, in line with previous recommendations (Moree & Davis, 2010; Reaven et al., 2009). 
For the school-aged cohort, the provision of visual structure and support, a predictable 
routine for each session, and a token reinforcement program were included to enhance the 
accessibility of the content. Use of multiple choice lists, written examples of core concepts, 
hand-on activities, an emphasis on creative outlets for expression, a focus on strengths and 
special interests, multiple opportunities for repetition and practice, and video self-modeling 
were used throughout both the original FYF program (Reaven et al., 2011), as well as the 
adolescent version (FYF-A; Reaven et al., unpublished manual). In addition to the 
modifications outlined in the original FYF, FYF-A incorporated technology (e.g., Apple 
iPod Touch), a social skills module, and increased opportunities for in-session exposure 
practice. Parents attended every session for the duration of the intervention, participating in 
the full 90-minute session across all age groups, although teens in the adolescent cohort 
worked more independently throughout the treatment program, while children in the 
younger cohort interacted more frequently with their parents. Both FYF and FYF-A include 
well-developed parent curricula that encourage parent support while reviewing key CBT 
components. Parents are also asked to increase awareness of their own anxiety and how the 
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anxiety may or may not influence parenting behaviors (Please refer to Reaven et al., 2012a; 
2012b for more detailed information regarding the FYF/FYF-A programs.)
Measures
Background information—Parents completed a demographic questionnaire on their 
children’s medical and early language history, race/ethnicity, parental education, and other 
family information.
Diagnosis of ASD—Diagnostic status was determined by expert clinical review of the 
ADOS (Lord et al., 2002) and the SCQ (Berument et al., 1999). The ADOS is a semi-
structured, play-based observational assessment of youth social and communicative 
behaviors indicative of ASD. It is considered best practice in clinical diagnosis of ASD, in 
conjunction with parent interview (National Research Council, 2001; Wilkinson, 2010). The 
instrument demonstrates sensitivity above 90% and specificity above 80% (Lord et al., 
2002). Research personnel were trained to 85% reliability on the full range of ADOS scores 
prior to administration, and 18% of ADOS assessments were videotaped and scored for 
inter-rater reliability. Mean percent agreement on algorithm items on Module 3 was 88% 
(range = 81–94%). The SCQ is a 40-item parent-report measure of lifetime and current 
symptoms of ASD. The measure has good specificity (.80) and sensitivity (.96) (Berument 
et al., 1999).
Cognitive screening—Potential participants lacking standardized cognitive assessment 
within two years prior to treatment were administered the Wechsler Abbreviated Scales of 
Intelligence (WASI; Weschler, 2002), a measure of verbal and nonverbal IQ, to help 
determine eligibility.
Screen for Child Anxiety Related Emotional Disorders—The SCARED—Parent 
version (Birmaher et al., 1999) is a 41-item, parent-report inventory of child anxiety 
symptoms. The measure includes five anxiety subscales (panic/somatic, generalized anxiety 
disorder (GAD), separation anxiety, social phobia, and school phobia), as well as a total 
score with an optimal cutoff of 25 for clinically significant anxiety (Birmaher et al., 1999). 
The SCARED demonstrates good convergent and divergent validity with other psychiatric 
assessment tools, as well as strong sensitivity (.71) and specificity (.67) in typically 
developing samples (Birmaher et al., 1997, 1999; Monga et al., 2000). Among youth with 
ASD, the parent and child versions of the SCARED show a similar five-factor structure, 
moderate convergent validity with the Anxiety Disorders interview Schedule (ADIS; 
Silverman & Albano, 1996), and good sensitivity (.71) and specificity (.67) (Stern, Gadgil, 
Blakeley-Smith, Reaven, & Hepburn, 2014). The extended 71-item version of the SCARED 
also shows strong internal consistency (α > 0.9) and moderate convergent validity with the 
ADIS among youth with ASD (van Steensel, Deutschman, & Bögels, 2012). Finally, the 
SCARED has been judged to be “potentially appropriate” as an outcome measure for 
anxiety in ASD (Lecavalier et al., 2014).
Parent report of youth anxiety was used in this study rather than child self-report due to the 
difficulties that youth with ASD have in identifying and expressing their own emotions 
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(Blakeley-Smith, Reaven, Ridge & Hepburn, 2012). In fact, some researchers have been 
reluctant to rely primarily on child self-report as an accurate reflection of symptom 
presentation because of the tendency of youth with ASD to under-report their symptoms 
(Chalfant, Rapee, & Carroll, 2007; Storch et al., 2012).
The SCARED was administered within six weeks prior to the start and following the end of 
each intervention group. Given that it was used as a post intervention measure, directions on 
the SCARED were modified to read “over the last 2 weeks” rather than “over the last 3 
months” for both administrative time points. The STAI and the SCARED were always 
completed during the same assessment session.
State-Trait Anxiety Inventory—As with the SCARED, parents of youth participants in 
the FYF treatment completed the State-Trait Anxiety Inventory (STAI; Spielberger, 
Gorsuch, Lushene, Vagg & Jacobs, 1983) within six weeks prior to the start and following 
the end of the intervention. The STAI is a widely used self-report measure of anxiety that 
differentiates between state anxiety (i.e., a temporary experience of anxiety in specific 
situations) and trait anxiety (i.e., a general, dispositional tendency to feel anxious across 
situations). The STAI consists of two 20-item scales (one for each type of anxiety). Scores 
for both scales range from 20 to 80, with higher scores indicating greater anxiety. Norms 
provided in the manual indicate mean state-anxiety scores for working adult males and 
females of 35.7 and 35.2, respectively. Mean trait-anxiety scores for these two groups are 
34.9 and 34.8, respectively (Spielberger et al., 1983). More recent research that examined 
control subjects, patients with anxiety disorders, and patients with mood disorders yielded 
mean state-anxiety scores of 41.6, 51.0, and 53.8 and mean trait-anxiety scores of 42.5, 52.9, 
and 58.7, respectively (Kaneda & Fujii, 2000). The measure demonstrates good internal 
consistency (αtrait scale = .89; αstate scale = .91), good test-retest reliability for the trait scale (r 
= .88) (Barnes, Harp, & Jung, 2002), and good concurrent validity with other anxiety 




To explore whether there were unique treatment effects depending on parental anxiety, 
children were classified as either treatment responders or non-responders. Positive treatment 
response was defined as having clinically significant anxiety prior to treatment (SCARED 
total score of 25 or greater) and non-clinical levels of anxiety following treatment (SCARED 
total score below 25). This is a fairly conservative estimate of the impact of this 
intervention, in that it only captures movement across the clinical cutoff of 25. For instance, 
a participant who had very high anxiety score of 41 prior to treatment and improved to a 
score of 26 following treatment would not be considered a treatment responder because the 
post-treatment score did not fall below 25. This is also a more conservative approach than 
was used for our inclusion criteria (i.e., above the clinical cutoff on one of three subscales, 
but not necessarily the SCARED total score). However, this framework was considered 
appropriate give the exploratory focus of this analysis.
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Of the 31 youth participants, 10 were characterized as treatment responders, while 21 
participants were characterized as treatment non-responders. Despite this conservative 
measure, 25 out of 31 participants (81%) reported a drop in anxiety symptoms, and 55% had 
a drop of at least 10 points reflecting a positive response to the intervention. Descriptive 
statistics were examined before exploring whether there were differences in parental anxiety 
between these groups. T-tests (paired and independent sample) with an alpha of .05 were 
used to examine potential between-group differences.
Baseline Parent and Child Anxiety Symptoms
Parental anxiety was assessed using the STAI (Spielberger et al., 1983), and child anxiety 
symptoms were assessed with the SCARED (Birmaher et al., 1999). Each measure was 
examined for normality and skewness prior to analysis. All variables had kurtosis and 
skewness statistics within acceptable parameters except state anxiety post-treatment, which 
was positively skewed. Visual analysis of the distribution revealed two outliers accounting 
for this skewness, and natural log transformations were run to normalize the distribution. 
This procedure resulted in acceptable kurtosis and skewness levels. Importantly, the results 
of all statistical tests on the transformed data were the same as on untransformed data. 
Therefore, the results presented here are on untransformed data to facilitate comparison of 
our data with those of previous studies (Conner et al., 2013; Spielberger et al., 1983).
Child anxiety symptoms reported by the parent on the SCARED did not differ significantly 
at baseline between responders (M = 37.6, SD = 5.89) and non-responders (M = 34.1, SD = 
17.9), t(29) = .60, p = .55; however, they did differ following treatment with responders 
reporting fewer symptoms (M = 17.0, SD = 7.3) than non-responders (M = 26.0, SD = 11.0), 
t(29)=2.4, p=.03.
Relationship between Parental Anxiety and Parent Report of Youth Anxiety
Prior to treatment, the mean state anxiety score for the whole group was 34.5 (SD = 10.6, 
range: 20–58), and the mean trait anxiety score was 37.6 (SD = 10.2, range: 23–62). These 
means are similar to both Conner et al. (2013) [state: t = .11, p = .97; trait: t = .53, p = .60] 
and the published norms Spielberger et al., 1983) [state: t = .35, p = .72; trait: t = 1.57, p = .
12]. There were no significant correlations between parental state anxiety and youth anxiety 
at baseline, r(31) = .21, p = .26, or post-treatment, r(31) = −.04, p = .84; neither were there 
significant correlations between parental trait anxiety and youth anxiety at baseline, r(31) = .
07, p = .73, or post-treatment, r(31) = −.04, p=.85.
Treatment Effects
There were no significant differences between parents of treatment responders and non-
responders reported on either state anxiety, t(29) = .29, p = .77, or trait anxiety, t(29) = 1.29, 
p = .21 at baseline. For parents of treatment responders, there was no change in parental 
state anxiety from pre-treatment (M = 35.3, SD = 10.0) to post-treatment (M = 32.5, SD = 
10.1), t = .77, p = 46. However, there was a significant improvement in parental trait anxiety 
from pre-treatment (M = 41.0, SD = 10.5) to post-treatment (M = 33.1, SD = 7.3), t = 2.63, p 
= .03 for parents of treatment responders. Parents of treatment non-responders, on the other 
hand, did not demonstrate improved state anxiety from pre-treatment (M = 30.0, SD = 9.9) 
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to post-treatment (M = 33.9, SD = 9.2), t(20) = 1.24, p = .23, or trait anxiety from pre- (M = 
34.1, SD = 11.0) to post-treatment (M = 32.5, SD = 8.9), t(20) = .80, p = .43.1
Discussion
The main objectives of the present study were: 1) to explore the relationship between 
parental anxiety and parent report of anxiety in youth with ASD; and 2) to examine the 
relationship between parental anxiety and response to treatment for anxiety in youth with 
ASD. Our first hypothesis was not supported, as results indicated that there was not a 
significant correlation between parent self-report of anxiety symptoms (neither state nor 
trait) and parent report of youth anxiety symptoms (measured via parent report on the 
SCARED) at either pre- or post-treatment. The lack of an association between parent self-
report of anxiety and parent report of youth anxiety differs from both the Conner et al. 
(2013) findings, as well as previous literature related to parent report of child anxiety 
symptoms in typically-developing populations (Hughes & Gullone, 2010).
There may be several explanations for the absence of a relationship between parental anxiety 
and parent report of youth anxiety in this study. First, it may be that parent participants were 
able to differentiate their own anxiety symptoms from their children’s symptoms, suggesting 
that reports of youth anxiety symptoms were not influenced by parents’ anxiety status. 
Alternatively, differences in measurement of youth anxiety between the present study and 
other studies (e.g., Conner et al., 2013) may contribute to the lack of an association between 
parent self-report and parent report of youth anxiety (e.g., Child Adolescent Symptom 
Inventory-20 (CASI-20; Sukhodolsky et al., 2008) vs. the SCARED). Finally, the null 
finding may have occurred because the sample was underpowered.
Results of the study did support our second hypothesis. That is, trait anxiety significantly 
decreased for parents of treatment responders, but not for parents of treatment non-
responders. State anxiety did not significantly improve for parents of treatment responders 
or non-responders. This finding indicates that parents of youth who improved after 
participation in the FYF treatment experienced their own reductions in trait anxiety. 
Improvement in anxiety symptoms for youth with ASD may have contributed to reductions 
in parental anxiety. Given that parents attended every session in the Facing Your Fears 
program for the entire 14 weeks, the strategies taught to youth with ASD might also have 
been helpful for some parents. Although strategies for identifying and managing parental 
anxiety are not directly targeted in FYF, there are discussions regarding parental anxiety and 
parenting style as it relates to youth anxiety. These discussions may have contributed to the 
observed decreases in parental trait anxiety.
The observed decrease in parental trait anxiety is consistent with findings reported by 
Conner et al. (2013), which indicated that trait anxiety decreased for parents of treatment 
responders, but not for parents of treatment non-responders. Our results also support the 
Conner et al. finding that children of more anxious parents were as likely to respond to 
1These analyses are based on the SCARED total score, however, when applied to the individual subscales used as inclusion criteria, 
the results are similar.
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treatment as were children of less anxious parents. This is in contrast to previous research 
with typically developing youth that found that parental anxiety negatively impact children’s 
response to treatment (Bodden et al., 2008; Cobham et al., 1998; Creswell & Cartwright-
Hatton, 2007; Creswell et al., 2008).
In sum, the present investigation and previous research exploring the relationship between 
parental anxiety and youth treatment outcome (i.e., Conner et al., 2013) included different 
measurement tools, unique intervention components, and participants from different age 
ranges. However, both studies found that trait anxiety decreased post-treatment for parents 
of treatment responders. Neither treatment program specifically targeted parental anxiety, 
although parents in both programs may have applied key CBT concepts to themselves as 
part of their participation in their child’s treatment program. Parents who participated in 
FYF did have the opportunity to directly discuss parental anxiety and the relationship 
between anxiety and parenting style; however, the extent to which this particular component 
of FYF contributed to the decreases in parental trait anxiety is unknown.
While modified CBT programs for youth with anxiety and ASD have demonstrated success 
for a majority of participants, there is still a substantial group of youth who do not 
demonstrate a significant, positive response to treatment (Reaven et al., 2012a; White et al., 
2013). In addition to examining intervention-, therapist-, and child-specific factors that 
might impact outcome, looking more closely at family factors such as parental anxiety may 
yield relevant information regarding why some children fail to respond or show only modest 
improvement. Even though the results from both the current study and the Conner et al. 
(2013) study suggests that youth of more anxious parents are as likely to respond to 
treatment compared to children of less anxious parents, both studies had relatively small 
sample sizes. Given the more consistent findings from the general pediatric literature 
(Creswell et al., 2008) that parental anxiety may significantly affect youth treatment 
outcome, it may be premature to take parental anxiety off the table as a critical variable to 
explore. In fact, further examination of the association between parental anxiety and youth 
anxiety treatment outcome may provide additional clues for what to emphasize in 
intervention programs. In addition, given limited research, we cannot yet identify the core 
components of existing interventions that are likely to yield improvements in child or 
parental anxiety, nor do we know that improvements in parental anxiety will in fact lead to 
improvements in anxiety for youth with ASD. Further research is needed to explore whether 
directly targeting parental anxiety or other parenting behaviors (e.g., parental 
overprotection) may potentiate youth and parent outcomes.
Limitations and Future Directions
Although the age range of youth participants in the present study was broader than in 
previous research, the current sample was still relatively small in size and included only 
youth and families who were seeking treatment. Although including a mix of both mother 
and father participants had been anticipated for the present study, the vast majority of parent 
participants were mothers (84%). Future studies should include more fathers in order to 
provide information about possible sex differences in parental anxiety and to examine 
whether mothers and fathers respond in the same way to anxiety interventions for 
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themselves and their children. An additional limitation was that parental anxiety was 
assessed using a single self-report measure (STAI), and that parents were asked to report on 
both their own anxiety as well as their child’s anxiety, reflecting a potential confound. 
Similarly, youth treatment outcome was measured using a single measure (SCARED). 
Given the overlap between anxiety symptoms and core deficits of ASD (Kerns & Kendall, 
2012), clinician interview of anxiety symptoms may be preferable to parent report. Thus, 
future research should include additional informants or methods of anxiety assessment for 
both parental anxiety as well as youth anxiety outcome.
Finally, the cross-sectional design of the current study limits our understanding of the 
directionality of findings. In other words, do youth treatment outcomes improve because 
parental anxiety decreases, or does parental anxiety decrease because their children respond 
to treatment? Silverman and colleagues (2009) reported that youth anxiety symptom 
improvement was associated with reductions in parental anxiety, even when parents were 
minimally involved in their child’s individual CBT treatment. Although these findings 
support the notion that youth-to-parent influence may occur in individual treatment settings, 
results may not be directly applicable to other treatment modalities, such as group 
interventions for youth with ASD. Process research involving more frequent assessment of 
parental and child anxiety symptoms during the course of treatment would help to identify 
directionality. As additional studies are completed, more specific recommendations can be 
offered for youth with ASD and anxiety who experience only limited responsiveness to 
treatment.
Despite these limitations, the current study contributes preliminary insights regarding the 
role of parental anxiety in treating anxiety symptoms in youth with ASD. Given the 
prevalence of anxiety in this population and critical role of parents in supporting positive 
outcomes for youth with developmental disabilities, further research is needed to unpack the 
interaction between parental anxiety and children’s response to anxiety interventions. This 
study raises new questions regarding how children and adolescents with ASD who struggle 
with anxiety can best be supported both at home and in treatment settings.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1






or N (%) Range
M (SD)
or N (%) Range
Child Characteristics
  Age in months 124.5 (26.8) 90–164 186.3 (15.2) 161–216
  Gender
    Male 10 (100%) 13 (62%)
    Female 0 (0%) 8 (38%)
  IQ 109.7 (11.5) 99–134 100.1 (17.6) 66–128
    Verbal 110.0 (20.2) 87–155 102.6 (16.9) 73–131
    Nonverbal 112.0 (9.7) 93–126 100.3 (18.0) 65–137
  Race/Ethnicity
    African American 0 (0%) 0 (0%)
    Asian 0 (0%) 1 (5%)
    Caucasian 9 (82%) 14 (67%)
    Hispanic/Latino 1 (9%) 4 (19%)
    Biracial/Other 0 (9%) 2 (9%)
Parent Characteristics
  Gender
    Mother 9 (901%) 17 (81%)
    Father 1 (10%) 4 (19%)
  Age in years 38.9 (5.0) 30–45 47.0 (9.8) 32–75
  Parent Education
    Partial High School 0 (0%) 0 (0%)
    High School Graduate 0 (0%) 3 (14%)
    Partial College 4 (36%) 5 (24%)
    College Graduate 5 (46%) 11 (52%)
    Post Graduate Training 1 (18%) 2 (10%)
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Table 2





M (SD) Range M (SD) Range
SCARED
  Pre Total 39.3 (6.9) 29–49 34.1 (17.8) 9–65
  Pre GAD 12.7 (2.0) 10–15 10.7 (4.7) 2–18
  Pre Social 10.3 (3.9) 1–14 7.6 (4.7) 0–14
  Pre Separation 5.4 (2.7) 2–10 4.6 (4.0) 0–14
  Post Total 17.3 (7.6) 4–25 26.0 (11.0) 4–46
  Post GAD 5.3 (2.3) 1–8 9.0 (3.7) 2–15
  Post Social 6.1 (4.3) 0–14 6.2 (4.0) 0–14
  Post Separation 2.0 (1.9) 0–6 3.1 (3.5) 0–11
STAI
  Pre State 34.1 (10.6) 21–57 34.1 (11.0) 20–58
  Pre Trait 38.0 (9.5) 30–62 36.0 (9.9) 23–59
  Post State 30.8 (9.9) 20–47 32.5 (8.9) 20–57
  Post Trait 33.0 (7.3) 23–46 33.9 (9.2) 20–54
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